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Abstract 
AIM: With the increased bacterial resistance and the resulting problems in recent years, it seems necessary to 
find new biocompatible compounds to confront this problem. This research was conducted to optimise the 
synthesis of cobalt oxide nanoparticles with the highest antibacterial activity. 
METHODS: In the present study, 9 experiments were designed using the Taguchi method. The effect of three 
factors of cobalt nitrate, KOH and the stirring time in the synthesis of cobalt oxide nanoparticles with the highest 
antibacterial activity was investigated. The bactericidal effect of synthesised nanoparticles was evaluated using 
the colony-forming unit (CFU) and disk diffusion methods. The characteristics of nanoparticles were studied using 
the Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and the scanning electron microscopy 
(SEM). 
RESULTS: The results indicated that all three evaluated factors were effective on the antibacterial properties of 
the synthesised nanoparticles. The best antibacterial activity of cobalt oxide nanoparticles was observed in 
experiment 9 (cobalt nitrate 0.6 M, KOH 2M and stirring time 60 min). The study of nanoparticles synthesised by 
FTIR, XRD, and SEM confirmed the formation of cobalt oxide nanoparticles with size (24 nm) and a proper 
structure (spinel structure). 
CONCLUSION: Due to the optimal antibacterial properties of the synthesised cobalt oxide nanoparticles, they can 
be used in the fabrication of dental and medical equipment with antibacterial properties. 
 
 
 
 
Introduction 
 
Despite significant advances in the treatment 
of diseases in recent decades, no proper cure has 
been still found for some diseases such as cancer [1], 
[2], cardiovascular diseases [3], chronic pains [4], 
diabetes [5], autoimmune diseases [6], [7], AIDS [8], 
[9], and microbial infections [10], [11]. Some common 
microbial infections with bacterial origin are strongly 
annoying. Since the discovery of bacteria, the 
researchers have always been looking for effective 
ingredients against them. The widespread introduction 
of antibiotics was made early in the last century. Since 
then, the bacterial resistance has grown significantly 
to the available antibiotics [12]. Over the years, 
bacteria have achieved effective mechanisms to cope 
with antibiotics through chromosomal mutations and 
genetic exchanges [13]. Escherichia coli and 
Staphylococcus aureus cause some of the most 
common infections in a variety of situations in society 
and hospitals. According to a report by the World 
Health Organization, the bacteria of Escherichia coli 
and Staphylococcus aureus have shown resistance to 
some common antibiotics in more than 50% of cases 
[14]. The development of resistance to antibiotics has 
limited their service life. Finding an antimicrobial agent 
is not an easy task due to poor penetration of the 
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compounds into the bacterial cells [15]. The traditional 
organic compounds used for the disinfection of toxic 
have side effects such as toxicity for humans and 
sensitivity to high temperatures and high pressures. 
In contrast, inorganic compounds are 
nontoxic, exhibit high antibacterial properties at low 
concentrations and are resistant to unfavourable and 
unbalanced conditions [16]. Due to the increased 
resistance of bacteria to antibiotics and their 
adaptability characteristics, finding new solutions to 
eliminate bacteria has become a priority nowadays. 
Over the past few decades, the use of 
nanotechnology and the synthesis and production of 
nanoparticles have brought new hopes for overcoming 
the antibacterial resistance. 
Cobalt oxide is one of the transition metal 
oxides, which is in the form of black powder with 
antimicrobial and magnetic properties. The magnetic 
nanoparticles are particles with an independent nature 
and a maximum dimension of 100 nm, which have 
magnetic properties. Due to its semistable three 
phases with various crystalline structures, cobalt is 
one of the most important magnetic metals. The 
crystalline cobalt oxide structures include the 
Hexagonal Closed Packed (HCP) phase, Face-
Centered Cubic (FCC) phase, and the Epsilon phase 
[17]. Due to the high capacity for use in various areas, 
magnetic nanoparticles of iron, cobalt, and nickel have 
drawn a lot of attention. The cobalt oxide 
nanoparticles, according to their properties, are used 
in various fields such as the synthesis of sensors, 
magnetic materials, electrochemical systems, smart 
absorbers, catalysts and in the medical area. 
Considering the use of cobalt oxide nanoparticles in 
different fields, optimising their synthesis seems to be 
important in terms of their application. The structures, 
sizes, morphologies and surface properties of 
nanoparticles can be improved by controlling the 
effective factors in the synthesis process [18], [19]. 
Therefore, changing and targeted determining the 
properties of nanoparticles can be considered 
according to their function and activity. Accordingly, 
this research was designed to optimise the synthesis 
of cobalt oxide nanoparticles as an antibacterial agent 
by using the co-precipitation method and evaluate its 
properties by employing Infrared Fourier transform 
infrared spectroscopy (FTIR), X-ray diffraction (XRD) 
and scanning electron microscopy (SEM) devices. 
 
 
Material and Methods 
 
Synthesis of cobalt oxide nanoparticles 
The cobalt oxide nanoparticles were 
synthesised using the coprecipitation method. The 
Qualitek-4 software and Taguchi method were used to 
optimise the synthesis of cobalt oxide nanoparticles 
with the highest antibacterial activity. To do so, 9 
experiments were designed and the effect of 0.2, 0.4 
and 0.6 M levels of Co(NO3)2.6H2O and the levels of 
1, 2 and 3 M of KOH at the stirring times of 30, 60, 
and 90 min were evaluated on the antibacterial activity 
of the synthesized nanoparticles (Table 1). 
Table 1: Taguchi design of experiments and antibacterial effect 
of manufactured cobalt oxide nanoparticles on gram-positive 
and gram-negative bacteria 
Experiment 
Cobalt nitrate 
(M) 
 KOH 
(M) 
 Stirring time 
(min) 
 Bacterial survival 
(Log10 CFU/ml) 
0.2 0.4 0.6  1 2 3  30 60 90  Gram-
positive 
Gram-
negative 
1  0.2    1    30   6.42 6.76 
2  0.2    2    60   5.84 6.13 
3  0.2    3    90   5.10 5.32 
4  0.4    1    60   5.32 5.51 
5  0.4    2    90   5.60 5.71 
6  0.4    3    30   4.94 5.06 
7  0.6    1    90   4.40 4.75 
8  0.6    2    30   4.76 4.89 
9  0.6    3    60   3.72 3.97 
 
A volume of 100 ml of KOH solution at 
concentrations of 1, 2 and 3 M and cobalt nitrates with 
the concentrations of 0.2, 0.4, and 0.6 M were 
prepared in separate containers. Then, according to 
the nine tests suggested by the Taguchi method, the 
solutions of KOH at different concentrations were 
added drop-by-drop to the containers containing 
cobalt nitrate solution while continuously stirring, 
which were mixed and combined at 30, 60 and 90 
min, respectively. Initially, pink sediment was formed, 
which was easily oxidised in contact with the air, and 
dark sediment was obtained. The dark sediment was 
separated by centrifugation and washed out with 
deionised water several times. It was then dried in an 
oven at 100°C for 24 h. The cobalt hydroxide powder 
was calcined in air at 400°C furnace for four hours to 
obtain the cobalt oxide nanoparticles. 
 
Antibacterial activity 
The antibacterial activity level of synthesised 
cobalt oxide nanoparticles according to 9 experiments 
suggested by Taguchi method against 
Staphylococcus aureus and Escherichia coli bacteria 
was studied using the colony-forming unit method. 
Bacterial suspensions were made from both bacteria 
with an approximate concentration of 10
8
 CFU/ml, 
which were shaken along with the synthesised 
nanoparticles for 6 h. The solutions containing 
bacterial suspensions and nanoparticles were 
incubated for 24 h at 37°C on a nutrient agar culture 
medium. After incubation, the colonies growth rate 
was calculated. Then, cobalt oxide nanoparticles were 
produced using the suggested conditions by Taguchi 
method, and their bactericidal effect was surveyed 
using CFU and disk diffusion methods. CFU method 
was done similar before and for disk diffusion test 
homogenous suspensions of Staphylococcus aureus 
and Escherichia coli bacteria were cultured by a swab 
on a nutrient agar medium. The discs containing 
cobalt oxide nanoparticles and Gentamycin (positive 
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control) were then placed on the media and incubated 
for 24 h at 37°C. Afterwards, the diameter of 
the zone of inhibition was measured for each disk 
[10]. 
 
 Characteristics 
After determining the optimal conditions 
based on the Taguchi method, the nanoparticles of 
cobalt oxide were synthesised under the proposed 
optimum conditions (cobalt nitrate 0.6 M, KOH 3M and 
stirring time 60 min) and their characteristics were 
evaluated. The FTIR spectrum of cobalt oxide 
nanoparticles was provided by the alpha spectrometer 
(Bruker, Germany) after the preparation of KBr tablets 
from the specimens. The X-ray diffraction test was 
performed by Philips X 'Pert (40 kV, 30 mA) to 
analyse and evaluate the crystalline structure formed 
in the synthesised nanoparticles. The microscopic 
images were taken of the cobalt oxide nanoparticles 
by a high-resolution scanning electron microscopy 
(TESCAN, Czech Republic) to examine the 
morphology and determine the size of the synthesised 
nanoparticles. 
 
Statistical analysis 
The data were analysed using Qualitek-4 
software (Nutek Inc., MI, USA). All tests were carried 
out three times with three replicated, and their 
averaging results were reported. 
 
 
Results 
 
One of the most important features of metal 
nanoparticles received considerable attention in 
recent years is their use as antibacterial compounds. 
Aimed at this, we used the Taguchi method to assess 
the effect of three factors of cobalt nitrate, KOH, and 
stirring time on the antibacterial activity of cobalt oxide 
nanoparticles (Table 1). The results indicated that the 
synthesised nanoparticles in experiment 9 (cobalt 
nitrate 0.6 M, KOH 2M, and stirring time of 60 min) 
had the highest antibacterial activity against gram-
positive bacteria (3.72) and gram-negative bacteria 
(3.97). 
The effect of each factor on the antibacterial 
properties of the synthesised cobalt oxide 
nanoparticles is displayed in Table 2.  
Table 2: The main effects of factors of cobalt nitrate, KOH and 
stirring times at different levels on the bacterial survival 
 
Factors 
Gram positive bacteria  
(S. aureus) 
 Gram-negative bacteria  
(E. coli) 
Level 1 Level 2 Level 3  Level 1 Level 2 Level 3 
Cobalt nitrate  5.79 5.29 4.29  6.07 5.43 4.54 
KOH  5.38 5.40 4.59  5.67 5.58 4.78 
Stirring time 5.37 4.96 5.03  5.57 5.20 5.26 
Cobalt nitrate, KOH, and the stirring time 
showed the highest performance in reducing the 
growth of Staphylococcus aureus in the third level 
(4.29), in the third level (4.59), and the second level 
(4.96), respectively. The studied factors had similar 
effects on the Escherichia coli as well. The optimal 
performance of cobalt nitrate (4.54) and KOH (4.78) 
was seen at the third level, while the stirring time 
(5.20) showed its bests at the second level. 
Table 3 shows the interaction effect between 
the concentrations of the cobalt salt, KOH and the 
stirring time. The interaction effect rate of the studied 
factors varied from 15.92 to 40.37 in the gram-positive 
bacteria and showed changes from 14.87 to 44.62 on 
the gram-negative bacteria. The highest interaction 
effect rate was seen in the case of KOH × Stirring 
time, while the lowest interaction rate was related to 
cobalt nitrate × KOH on both gram-positive and gram-
negative bacteria.  
Table 3: The interactions among studied factors on the survival 
rate of bacteria 
 Interacting factor pairs Column 
Severity Index 
(%) 
Optimum 
conditions 
Gram-positive bacteria 
(S. aureus) 
KOH × Stirring time 2×3 40.37 [3,2] 
Cobalt nitrate × Stirring 
time 
1×3 17.77 [3,2] 
Cobalt nitrate × KOH 1×2 15.92 [3,3] 
Gram-negative bacteria 
(E. coli) 
KOH × Stirring time 2×3 44.62 [3,2] 
Cobalt nitrate × Stirring 
time 
1×3 19.35 [3,2] 
Cobalt nitrate × KOH 1×2 14.87 [3,3] 
 
The analysis of variance of the examined 
factors (cobalt nitrate, KOH, and stirring time) is 
presented in Table 4. According to the results, the 
factors of cobalt nitrate, KOH and the stirring time 
respectively indicated the optimal effect on the 
synthesis of nanoparticles with the highest 
antibacterial activity against gram-positive and gram-
negative bacteria. 
Table 4: The ANOVA test for studied factors on reducing the 
growth of bacteria 
Type of bacteria Factors DOF 
Sum of 
Squares 
Variance 
F-Ratio 
(F) 
Pure 
Sum 
Percent 
(%) 
Gram positive 
bacteria 
(S. aureus) 
Cobalt nitrate 2 3.47 1.73 49.74 3.40 66.35 
KOH 2 1.29 0.64 18.53 1.22 23.86 
Stirring time 2 0.29 0.14 4.19 0.22 4.34 
Gram negative 
bacteria (E. coli) 
Cobalt nitrate 2 3.56 1.78 39.18 3.47 65.25 
KOH 2 1.43 0.71 15.76 1.34 25.22 
Stirring time 2 0.23 0.12 2.57 0.14 2.69 
DOF, degree of freedom. 
 
The optimum conditions for the synthesis of 
cobalt oxide nanoparticles with the most favourable 
antibacterial activity are reported in Table 5. The 
results suggested that the use of cobalt nitrate and 
KOH at the third level and the stirring time at the 
second level can provide the optimal antibacterial 
performance for the synthesis of cobalt oxide 
nanoparticles. The antibacterial performance rate of 
synthesised nanoparticles in the optimal conditions 
improved compared to the average performance of 
the synthesised nanoparticles in the 9 experiments. 
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Table 5: Predicted the optimal conditions for producing cobalt 
oxide nanoparticles with the highest antibacterial activity 
Factors 
Gram-positive bacteria  
(S. aureus) 
Gram-negative bacteria  
(E. coli) 
Level Contribution Level Contribution 
Cobalt nitrate 3 0.83 3 0.81 
KOH  3 0.54 3 0.56 
Stirring time 2 0.16 2 0.14 
Total contribution from all factors  1.53  1.51 
Current grand average of the 
performance 
 5.12  5.34 
Bacterial survival at optimum 
condition 
 3.59  3.83 
 
Table 6 shows the level of antibacterial 
activity of the cobalt oxide nanoparticles synthesised 
under the proposed optimum conditions against 
Staphylococcus aureus and Escherichia coli bacteria. 
Evaluating the bactericidal effect of synthesised cobalt 
oxide nanoparticles by CFU method demonstrated 
that the growth rate of gram-positive and gram-
negative bacteria reduced to 3.60 and 3.78, 
respectively. In the disc diffusion method, inhibition 
zone diameters for gram-positive and gram-negative 
bacteria were 15 and 14.66, respectively. The slight 
difference was observed in the bactericidal activity of 
cobalt oxide nanoparticles and antibiotic (gentamicin) 
against Staphylococcus aureus and Escherichia coli 
bacteria that denoting the favourable bactericidal 
effect of synthesised cobalt oxide nanoparticles. 
Table 6: The bactericidal activity of synthesised cobalt oxide 
nanoparticles in optimal conditions 
Type of essay Type of bacteria 
Bactericidal activity  
Cobalt 
Oxide 
Gentamycin 
Bacterial survival (Log10 
CFU/ml) 
Gram positive bacteria (S. aureus) 3.60 2.56 
Gram negative bacteria (E. coli) 3.78 2.84 
Zone of inhibition (mm) 
Gram-positive bacteria (S. 
aureus) 
15 17 
Gram negative bacteria (E. coli) 14.66 15.66 
 
Examining the properties of nanoparticles 
showed that the synthesised nanoparticles have a 
suitable structure and size for biological applications. 
Figure 1 shows the FTIR spectrum of cobalt oxide 
nanoparticles in the range of 400-4000 cm
-1
 
wavelengths. Some peaks were found in the range of 
667 cm
-1
 and 574 cm
-1
 in the FTIR spectrum of cobalt 
oxide nanoparticles, which represented the synthesis 
of cobalt oxide nanoparticles. The peaks observed in 
the FTIR spectrum of the synthesised nanoparticles 
confirm the spinel structure of the cobalt oxide 
nanoparticles. 
 
Figure 1: FTIR spectra synthesised cobalt oxide nanoparticles 
The phase formation and crystallography of 
cobalt oxide nanoparticles were investigated using the 
X-ray diffraction (Figure 2). The nature of peaks in the 
XRD pattern of cobalt oxide nanoparticles was by the 
JCPDS 74-2120, suggesting the cubic structure of the 
synthesised nanoparticles. Considering the magnetic 
properties of these nanoparticles, they are suitable for 
use in various fields, including biological and medical 
applications. 
 
Figure 2: XRD pattern of synthesised cobalt oxide nanoparticles 
 
The scanning electron microscopy images 
were used to study the structure and morphology of 
the synthesised cobalt oxide nanoparticles (Figure 3). 
The analysis of the scanning electron micrographs 
revealed the agglomeration of some cobalt oxide 
nanoparticles. According to the SEM image, the 
approximate average size of the synthesised 
nanoparticles was about 24 nm. The nanoparticles 
had a relatively rugged surface and a spherical shape, 
resulting in higher adsorption sites and their better 
interactions. 
 
Figure 3: SEM image of synthesised cobalt oxide nanoparticles 
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Discussion 
 
Regarding the use of metal oxide 
nanoparticles in various fields, optimising their 
synthesis can be important in terms of their 
application. Previous studies have shown that the 
factors effective in the synthesis of nanoparticles can 
affect their shape, size, and properties [10], [20]. 
The evaluation of the antibacterial properties 
of the synthesised cobalt oxide nanoparticles 
indicated a significant reduction in the colony 
formation of studied gram-positive and gram-negative 
bacteria. Consistent with the results of this study, 
previous studies have reported the antibacterial 
activity of cobalt oxide nanoparticles alone or in 
combination with other materials [21], [22], [23]. In 
research, Alsharaeh et al. [24] evaluated the synthesis 
of graphene-cobalt oxide nanocomposite and its 
antibacterial properties. According to them, a 
compound contacting cobalt oxide nanoparticles 
shows a desirable antibacterial effect against gram-
negative bacteria. The precise mechanism of action of 
the cobalt oxide nanoparticles, which kills the bacteria, 
is still unclear and no specific mechanism has been 
suggested in this regard. However, due to 
mechanisms of action of other nanoparticles, probably 
processes such as the induction of oxidative stress, 
the release of toxic metal ions and damage to the cell 
membrane and interfering its activities can generate 
the antimicrobial properties of cobalt oxide 
nanoparticles [25], [26]. 
Due to the rapidly growing use of metal 
nanoparticles in the therapeutic applications, the 
targeted optimisation of their synthesis seems to be 
important regarding their application. Applying the 
Taguchi method, we determined the optimum 
conditions for the synthesis of cobalt oxide 
nanoparticles with the highest antibacterial activity 
(experiment 9). The results on antibacterial activity of 
factors effective in the synthesis of cobalt oxide 
nanoparticles showed that the cobalt nitrate and KOH 
at the third level and the stirring time at the second 
level had a greater effect on the antibacterial 
properties of the synthesized nanoparticles against 
the gram-positive bacteria of Staphylococcus aureus 
and the gram-negative bacteria of Escherichia coli. 
The results of FTIR, XRD, and SEM analyses 
revealed that the cobalt oxide particles were 
synthesised in nanoscale with a spherical form, a 
relatively uniform size and a high crystallisation 
degree. Due to the optimal antibacterial activity and 
proper stability of the cobalt oxide nanoparticles, they 
can be used as an alternative to conventional 
antibacterial compounds to combat the pathogenic 
bacteria. 
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